We recently revamped our “99213″ publication for community providers. “In Practice” is an expanded publication with themed issues by major service line. The goal of the publication is to equip community providers with helpful information to manage their practice and enhance patient care. The first issue focuses on our DeCesaris Cancer Institute. All medical staff members will receive a copy in the mail. View the issue here.
Medical Staff Updates
A 2-hour diagnostic protocol for possible cardiac chest pain in the Emergency Department and commentary: Rapid evaluation of chest pain in the Emergency Departmentby jmiller on January 24, 2014
From JAMA, (Jan), concludes: “Using the accelerated diagnostic protocol in the experimental pathway almost doubled the proportion of patients with chest pain discharged early. Clinicians could discharge approximately 1 of 5 patients with chest pain to outpatient follow-up monitoring in less than 6 hours. The diagnostic strategy could be easily replicated in other centers because no extra resources are required. Click here to read full-text.
The AAMC Foundation 2014 Annual Fundraising Gala is Saturday, April 12, 2014, 5:30pm to midnight at the Hyatt Regency in Baltimore. The black-tie festivities include dinner, dancing to live music by the band “Right On,” and silent and live auctions. Details about sponsorship opportunities are available here. Download the sponsorship e-form here.
The 2014 Spring Gala celebrates Anne Arundel Medical Center and our “Care Beyond the Walls.” Every year, AAMC contributes tens of millions of dollars in care to the most vulnerable in our community, people living at or below poverty level. Many of the citizens benefiting from our services are dealing with debilitating physical and mental illness or even addiction. It is philanthropic support that makes this vital care possible.
Tickets are $ 300 per person, for more information on the 2014 Gala call Kendra Smith Houghton, Special Events Officer, Anne Arundel Medical Center Foundation 443-481-4739 or email khoughton@AAHS.org.
The DeCesaris Cancer Institute and Rehabilitation Medicine are excited to announce the development of a comprehensive cancer rehabilitation program. Carol Tweed, MD, will serve as medical advisor.
Twenty-five clinicians from across the rehabilitation and cancer institute departments have been selected to receive training in the first session. Our goal is to have the program fully developed and “STAR”-certified by March 2014. STAR stands for Survivorship Training and Rehab Program.
What does it mean to be a “ STAR” certified program? The “STAR” certification program operating under the name of Oncology Rehabilitation Partners was developed by Dr. Julie Silver at Harvard Medical School. It has been implemented by more than 75 hospitals and cancer centers nationwide including Johns Hopkins Hospital. This program aims to provide healthcare professionals with new or enhanced knowledge that can be implemented in the evaluation and management of cancer and treatment-related impairments, ultimately ensuring the safe and effective restoration of cancer survivor’s function and quality of life. Emphasis will be placed on evidence based practice, understanding rationales for therapeutic interventions, as well as identifying areas where future research is needed in the field of cancer rehabilitation. “STAR” certification includes online educational training, expert-directed webinars, on-site self-directed in-service instructions, implementation support, outcomes measurements and support, marketing materials and continuing education.
The development of the comprehensive cancer rehabilitation program will involve a considerable combined effort among the professionals in the Cancer Institute, Outpatient Rehabilitation, Inpatient Rehabilitation, and Pulmonary Rehabilitation services. The complexity of developing an oncology rehab program requires provider expertise, consistent standards of education and treatment, and adherence to guidelines to achieve outcomes. Above all, it takes a commitment from all departments where these services are offered to come together as one team and achieve the standards we set. In addition, six patient and family advisers have been selected to work with of us providing valuable insight as we go along.
We are confident that we will achieve success together and make a difference for our cancer patients. Contact your director for more information or contact Cathy Copertino, executive director of the DeCesaris Cancer Institute, at 443-481-1336 or ccopertino@AAHS.org.
The Baltimore Business Journal recently noted AAMC as the third busiest hospital (measured by admissions) in the Baltimore region. In addition, we were noted for high quality in maternity care, surgery, and overall quality as rated by patients. Click here to read the article.
“Safety and effectiveness of recombinant human bone morphogenetic protein-2 for spinal fusion”; “Effectiveness and harms of recombinant human bone morphogenic protein-2 in spine fusion” and editorial, “Closing in on the truth about recombinant morphogenetic protein-2″by jmiller on November 12, 2013
These two review articles and accompanying editorial (Ann Intern Med, June 18). Two independent studies suggesting that rhBMP-2 has no proven clinical advantage over bone graft and may be associated with important harms, making it difficult to identify clear indications for rhBMP-2. “The clinical question is of greta interest to orthopedic surgeons and relevant to internists who encounter patiens who have had or are considering having spinal fusion. These dual reviews spotlight the power of evidence sythesis, data sharing, peer review, and reproducible research.” Click here to read full text.
This article (NEJM, Oct 17) was the subject of a recent update in the Dynamed database. It concludes: “In patients with acute pericarditis, colchicine, when added to conventional anti-inflammatory therapy, significantly reduced the rate of incessant or recurrent pericarditis, especially in patients with a first episod. Click here to read ful text.
In this New England Journal of Medicine “Clinical Pracitce” summation (Oct. 17) , the potential benefits and harms of calcium intake are reviewed. Several studies have raised concerns about a possible increase in cardiovascualr ris associated with calcium supplementation as well as nephrolithiasis. Pending further data, “a reasonable approach is to preferentially encourage dietary calcium intake and discourage the routine use of calcium supplements”. click here to view full-text.